KRAS mutation testing in colorectal cancer as an example of the pathologist's role in personalized targeted therapy: a practical approach.

@article{Domagaa2012KRASMT,
  title={KRAS mutation testing in colorectal cancer as an example of the pathologist's role in personalized targeted therapy: a practical approach.},
  author={P. Domagała and J. Hybiak and V. Sulżyc-Bielicka and C. Cybulski and J. Ryś and W. Domagała},
  journal={Polish journal of pathology : official journal of the Polish Society of Pathologists},
  year={2012},
  volume={63 3},
  pages={
          145-64
        }
}
Identifying targets for personalized targeted therapy is the pathologist's domain and a treasure. For decades, pathologists have had to learn, understand, adopt and implement many new laboratory techniques as they arrived on the scene. Pathologists successfully integrate the results of those tests into final pathology reports that were, and still are, the basis of clinical therapeutic decisions. The molecular methods are different but no more difficult to comprehend in the era of "kit… Expand
31 Citations
KRAS mutations: analytical considerations.
  • 27
  • Highly Influenced
Expanding Role of Bio Markers in Colo-Rectal Cancer (CRC)
  • 1
Extended RAS testing in metastatic colorectal cancer-Refining the predictive molecular biomarkers.
  • 27
Concordance of KRAS mutation status between luminal and peripheral regions of primary colorectal cancer. A laser-capture microdissection-based study.
  • 3
  • PDF
...
1
2
3
4
...

References

SHOWING 1-10 OF 147 REFERENCES
KRAS Mutation Testing in Human Cancers: The Pathologist's Role in the Era of Personalized Medicine
  • 88
  • Highly Influential
Clinical implementation of KRAS testing in metastatic colorectal carcinoma: the pathologist's perspective.
  • J. Ross
  • Medicine
  • Archives of pathology & laboratory medicine
  • 2012
  • 20
  • Highly Influential
KRAS Mutations Testing in Colorectal Carcinoma Patients in Italy: From Guidelines to External Quality Assessment
  • 33
  • PDF
Laboratory methods for KRAS mutation analysis
  • S. Anderson
  • Biology, Medicine
  • Expert review of molecular diagnostics
  • 2011
  • 47
Epidermal growth factor receptor pathway mutations and colorectal cancer therapy.
  • 20
Molecular diagnostics of colorectal cancer.
  • 56
  • Highly Influential
KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection.
  • 210
  • PDF
Study of KRAS new predictive marker in a clinical laboratory
  • 8
  • Highly Influential
...
1
2
3
4
5
...